MedTrace Logo

A Blood Test to Diagnose Kawasaki Disease

NCT05091229 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-03-23

No results posted yet for this study

Summary

A case-control cohort study is being conducted to develop and validate the performance of a whole blood gene expression qPCR test to distinguish KD from other febrile conditions by collecting whole blood sample from KD patients in the first 7 days of illness and from febrile controls immediately after presentation and before clinical diagnosis is confirmed.

Conditions

  • Kawasaki Disease

Sponsors & Collaborators

  • Shanghai Children's Medical Center

    collaborator OTHER

  • mProbe Inc.

    collaborator INDUSTRY

  • HBI Solutions Inc.

    lead INDUSTRY

Principal Investigators

  • Hao Zhang, M.D · Shanghai Children's Medical Center

Eligibility

Min Age
6 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05091229 on ClinicalTrials.gov